Your browser doesn't support javascript.
loading
Migration history and risk of psychosis: results from the multinational EU-GEI study.
Tarricone, Ilaria; D'Andrea, Giuseppe; Jongsma, Hannah E; Tosato, Sarah; Gayer-Anderson, Charlotte; Stilo, Simona A; Suprani, Federico; Iyegbe, Conrad; van der Ven, Els; Quattrone, Diego; di Forti, Marta; Velthorst, Eva; Rossi Menezes, Paulo; Arango, Celso; Parellada, Mara; Lasalvia, Antonio; La Cascia, Caterina; Ferraro, Laura; Bobes, Julio; Bernardo, Miguel; Sanjuán, Iulio; Santos, Jose Luis; Arrojo, Manuel; Del-Ben, Cristina Marta; Tripoli, Giada; Llorca, Pierre-Michel; de Haan, Lieuwe; Selten, Jean-Paul; Tortelli, Andrea; Szöke, Andrei; Muratori, Roberto; Rutten, Bart P; van Os, Jim; Jones, Peter B; Kirkbride, James B; Berardi, Domenico; Murray, Robin M; Morgan, Craig.
Afiliação
  • Tarricone I; Department of Medical and Surgical Sciences, Bologna Transcultural Psychosomatic Team (BoTPT), University of Bologna, Bologna, Italy.
  • D'Andrea G; Department of Mental Health and Pathological Addiction, Local Health Authority, Bologna, Italy.
  • Jongsma HE; Department of Medical and Surgical Sciences, Bologna Transcultural Psychosomatic Team (BoTPT), University of Bologna, Bologna, Italy.
  • Tosato S; Department of Biomedical and NeuroMotor Sciences, Psychiatry Unit, Alma Mater Studiorum Università di Bologna, Bologna, Italy.
  • Gayer-Anderson C; PsyLife Group, Division of Psychiatry, UCL, London, England.
  • Stilo SA; Department of Psychiatry, University of Cambridge, Cambridge, England.
  • Suprani F; Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Piazzale L.A. Scuro 10, 37134, Verona, Italy.
  • Iyegbe C; Department of Health Service and Population Research, Institute of Psychiatry, King's College London, London, UK.
  • van der Ven E; Department of Mental Health and Addiction Services, ASP Crotone, Crotone, Italy.
  • Quattrone D; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, England.
  • di Forti M; Department of Medical and Surgical Sciences, Bologna Transcultural Psychosomatic Team (BoTPT), University of Bologna, Bologna, Italy.
  • Velthorst E; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, England.
  • Rossi Menezes P; Mailman School of Public Health, Columbia University, New York, NY, USA.
  • Arango C; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Parellada M; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 8AF, UK.
  • Lasalvia A; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 8AF, UK.
  • La Cascia C; Department of Psychiatry, Early Psychosis Section, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
  • Ferraro L; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA.
  • Bobes J; University Hospital, Section of Epidemiology, University of São Paulo, São Paulo, Brazil.
  • Bernardo M; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, CIBERSAM, Centro de Investigación Biomédica en Red de Salud Mental, Madrid, Spain.
  • Sanjuán I; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, CIBERSAM, Centro de Investigación Biomédica en Red de Salud Mental, Madrid, Spain.
  • Santos JL; Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Piazzale L.A. Scuro 10, 37134, Verona, Italy.
  • Arrojo M; Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, Via G. La Loggia 1, 90129, Palermo, Italy.
  • Del-Ben CM; Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, Via G. La Loggia 1, 90129, Palermo, Italy.
  • Tripoli G; Department of Medicine, Psychiatry Area, School of Medicine, Universidad de Oviedo, Centro de Investigación Biomédica en Red de Salud Mental, Oviedo, Spain.
  • Llorca PM; Barcelona Clinic Schizophrenia Unit, Department of Medicine, Neuroscience Institute, Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Centro de Investigación Biomédica en Red de Salud Mental, Barcelona, Spain.
  • de Haan L; Department of Psychiatry, School of Medicine, Universidad de Valencia, Centro de Investigación Biomédica en Red de Salud Mental, Valencia, Spain.
  • Selten JP; Department of Psychiatry, Servicio de Psiquiatría Hospital 'Virgen de la Luz', Cuenca, Spain.
  • Tortelli A; Department of Psychiatry, Psychiatric Genetic Group, Instituto de Investigación Sanitaria de Santiago de Compostela, Complejo Hospitalario Universitario de Santiago de Compostela, Spain.
  • Szöke A; Neuroscience and Behavior Department, Ribeirão Preto Medical School, University of São Paulo, Brazil.
  • Muratori R; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, England.
  • Rutten BP; Department of Biomedicine, neurosciences, and advanced diagnostics, University of Palermo, Italy.
  • van Os J; Université Clermont Auvergne, EA 7280 Npsydo, Clermont-Ferrand, France.
  • Jones PB; Department of Psychiatry, Early Psychosis Section, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
  • Kirkbride JB; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Berardi D; Etablissement Public de Santé Maison Blanche, Paris, France.
  • Murray RM; Univ Paris Est Creteil (UPEC), AP-HP, Hôpitaux Universitaires « H. Mondor ¼, DMU IMPACT, INSERM, IMRB, Fondation FondaMental, F-94010 Creteil, France.
  • Morgan C; Department of Mental Health and Pathological Addiction, Local Health Authority, Bologna, Italy.
Psychol Med ; 52(14): 2972-2984, 2022 10.
Article em En | MEDLINE | ID: mdl-33563347
ABSTRACT

BACKGROUND:

Psychosis rates are higher among some migrant groups. We hypothesized that psychosis in migrants is associated with cumulative social disadvantage during different phases of migration.

METHODS:

We used data from the EUropean Network of National Schizophrenia Networks studying Gene-Environment Interactions (EU-GEI) case-control study. We defined a set of three indicators of social disadvantage for each phase pre-migration, migration and post-migration. We examined whether social disadvantage in the pre- and post-migration phases, migration adversities, and mismatch between achievements and expectations differed between first-generation migrants with first-episode psychosis and healthy first-generation migrants, and tested whether this accounted for differences in odds of psychosis in multivariable logistic regression models.

RESULTS:

In total, 249 cases and 219 controls were assessed. Pre-migration (OR 1.61, 95% CI 1.06-2.44, p = 0.027) and post-migration social disadvantages (OR 1.89, 95% CI 1.02-3.51, p = 0.044), along with expectations/achievements mismatch (OR 1.14, 95% CI 1.03-1.26, p = 0.014) were all significantly associated with psychosis. Migration adversities (OR 1.18, 95% CI 0.672-2.06, p = 0.568) were not significantly related to the outcome. Finally, we found a dose-response effect between the number of adversities across all phases and odds of psychosis (⩾6 OR 14.09, 95% CI 2.06-96.47, p = 0.007).

CONCLUSIONS:

The cumulative effect of social disadvantages before, during and after migration was associated with increased odds of psychosis in migrants, independently of ethnicity or length of stay in the country of arrival. Public health initiatives that address the social disadvantages that many migrants face during the whole migration process and post-migration psychological support may reduce the excess of psychosis in migrants.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Migrantes Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Psychol Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Migrantes Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Psychol Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália
...